Copyright
©The Author(s) 2022.
World J Diabetes. Aug 15, 2022; 13(8): 600-612
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.600
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.600
Figure 4 Clopidogrel inhibits the expression of tumor necrosis factor-α and interleukin-1β in db/db mice.
Data are shown as mean ± SD values of n = 6 per group. aP < 0.05 vs wild-type mice; bP < 0.05 vs db/db mice. A: Tumor necrosis factor (TNF)-α and interleukin (IL)-1β gene expression, determined using real-time polymerase chain reaction; B: Immunohistochemical staining; C: Semi-quantitative analysis of TNF-α and IL-1β protein expression. WT: Wild type; db/db: db/db mice; Clo: Clopidogrel; TNF: Tumor necrosis factor; IL: Interleukin.
- Citation: Li HQ, Liu N, Zheng ZY, Teng HL, Pei J. Clopidogrel delays and can reverse diabetic nephropathy pathogenesis in type 2 diabetic db/db mice. World J Diabetes 2022; 13(8): 600-612
- URL: https://www.wjgnet.com/1948-9358/full/v13/i8/600.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i8.600